laevo-ornithine laevo-aspartate

(2S)-2- amino-4-hydroxy-4-oxobutanoate; [(4S)-4-amino-5-hydroxy-5-oxopentyl]azanium L- aspartic acid compd. with L-ornithine (1:1) laevo- aspartic acid compd. with laevo-ornithine (1:1) ornithine aspartate L- ornithine L-aspartate ornithyl aspartate PubMed: [The use of remaxol in combined intensive therapy of acute mushroom poisoning]. PubMed: [Meta-analysis of the efficacy and safety of telaprevir combined with peginterferon alfa plus ribavirin in patients with chronic hepatitis C]. PubMed: [Ornithine aspartate and naloxone combined therapy for hepatic encephalopathy affects cognitive function, prognosis, and neuropeptide levels]. PubMed: [Hepatic dysfunction correction in patients with obturation jaundice]. PubMed: Modulation of neural activation following treatment of hepatic encephalopathy. PubMed: l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials. PubMed: Sequence position and side chain length dependence of charge pair interactions in collagen triple helices. PubMed: [Hepatic encephalopathy and liver transplantation]. PubMed: Critical analysis of studies evaluating the efficacy of infusion of L-ornithine L-aspartate in clinical hepatic encephalopathy in patients with liver failure. PubMed: Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. PubMed: [Optimization of treatment of patients with chronic cardiac insufficiency of the ischemic genesis and hobnail liver]. PubMed: Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy. PubMed: A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. PubMed: The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition. PubMed: Hepatic encephalopathy. PubMed: [Study on L-Ornithine-L-Aspartate in the treatment of acute-on-chronic liver failure]. PubMed: Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study. PubMed: Effect of l-ornithine l-aspartate against thioacetamide-induced hepatic damage in rats. PubMed: Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy. PubMed: Interorgan ammonia metabolism in liver failure: the basis of current and future therapies. PubMed: [Physiological functions of L-ornithine and L-aspartate in the body and the efficacy of administration of L-ornithine-L-aspartate in conditions of relative deficiency]. PubMed: [Reduction of hospital stay with the use of L-ornithine L-aspartate (LOLA) in patients with hepatic encephalopathy]. PubMed: [Hepatic encephalopathy. L-ornithine-L-aspartate stimulate detoxification capacity of the liver]. PubMed: Pharmacotherapy for hepatic encephalopathy. PubMed: A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis. PubMed: Metal toxicity, liver disease and neurodegeneration. PubMed: Minimal hepatic encephalopathy. PubMed: A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment. PubMed: Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. PubMed: Treatment of hyperammonemia in liver failure: a tale of two enzymes. PubMed: L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy. PubMed: L-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis. PubMed: [Efficiency of prevention and treatment of veno-occlusive disease of the liver after allogeneic stem cell transplantation]. PubMed: [New approach to diagnostics and correction of portohepatic hemodynamics in patients with chronic liver diseases]. PubMed: [Fulminate liver failure in a 39-year-old female patient with leukocytosis, unclear fever, and arthralgic pain]. PubMed: Hepatic encephalopathy: pathophysiology and advances in therapy. PubMed: The treatment of hepatic encephalopathy. PubMed: Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): management with L-ornithine-L-aspartate and stent reduction. PubMed: Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study. PubMed: Hepatic encephalopathy: a review of its pathophysiology and treatment. PubMed: Effect of ascorbic acid, alpha-tocopherol, lecithin and L-ornithine-L-aspartate on ethanol induced hypoproteinemia and hyperlipidemia in rats. PubMed: Pharmacokinetics and bioavailability study of L-ornithine-L-aspartate in healthy volunteers--a comparative study of two oral formulations. PubMed: Validated method for L-ornithine-L-aspartate analysis in human plasma by capillary electrophoresis. PubMed: [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy]. PubMed: Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy. PubMed: [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)]. PubMed: [New concepts in the physiopathology of hepatic encephalopathy and therapeutic prospects]. PubMed: [Cirrhotic liver gives up in breaking up of ammonia. Poison for the brain]. PubMed: Brain edema in acute liver failure. PubMed: [Because hepatic encephalopathy is a frequent contributing factor. Patients with liver cirrhosis are poorer drivers]. PubMed: [Hepatic encephalopathy--therapy]. PubMed: Hepatic encephalopathy: nomenclature, pathogenesis and treatment. PubMed: Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy. PubMed: Liver transplantation improves hepatic myelopathy: evidence by three cases. PubMed: Management of hepatic encephalopathy. PubMed: [Researching progress of prevention and treatment of hepatic failure encephalopathy]. PubMed: [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis]. PubMed: Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment--results of a pilot study. PubMed: [Chronic liver diseases. The nihilism has gone]. PubMed: [In liver cirrhosis, not every "ammonia lowering drug" improves neuropsychiatric deficit]. PubMed: Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial. PubMed: [Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?]. PubMed: Complications of cirrhosis III. Hepatic encephalopathy. PubMed: L-ornithine aspartate - a rationale for its use in combination with chemotherapy, radiation, and hyperthermia in oncology. PubMed: L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure. PubMed: L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action. PubMed: Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. PubMed: Treatment of cirrhotic rats with L-ornithine-L-aspartate enhances urea synthesis and lowers serum ammonia levels. PubMed: Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. PubMed: L-ornithine vs. L-ornithine-L-aspartate as a treatment for hyperammonemia-induced encephalopathy in rats. PubMed: Review article: pathogenesis and treatment of chronic hepatic encephalopathy. PubMed: Contrasting effects of thioacetamide-induced liver damage on the brain uptake indices of ornithine, arginine and lysine: modulation by treatment with ornithine aspartate. PubMed: [Hepatic minimal encephalopathy. The most frequently overlooked, clinically occult "metabolic syndrome" on the cirrhosis patient]. PubMed: [The treatment of hepatic encephalopathy with Hepa-Mertz]. PubMed: [Ornithine aspartate in hepatic encephalopathy: an established new therapeutic approach. Overview and results of current randomized studies]. PubMed: Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design. PubMed: Long-term effectiveness of high-dosed ornithine-aspartate on urea synthesis rate and portal hypertension in human liver cirrhosis. PubMed: [Amino acids prevent hepatic encephalopathy. Ornithine-aspartate in hyperammonemia--results of a study]. PubMed: X-ray studies on crystalline complexes involving amino acids and peptides. IX. Crystal structure of L-ornithine L-aspartate hemihydrate. PubMed: [Influence of ornithine aspartate on the experimentally induced hyperammoniemia. Clinico-experimental study]. PubMed: Intravenous loading with arginine-hydrochloride and ornithine-aspartate in siblings of two families, presenting a familial neurological syndrome associated with cystinuria. PubMed: [Clinical experiences in liver diseases (specially in patients with fatty liver due to alcoholism and food poisoning) under monotherapy with ornithine aspartate]. PubMed: [Influence of ornithine-aspartate on the increased GOT activity in bovine serum]. PubMed: [Further clinical experiences with ornithine aspartate in liver diseases]. PubMed: [Effect of ornithine-aspartate on fecal excretion of mevalonate metabolites and the reticuloendothelial system]. PubMed: [Our clinical experience with ornithine aspartate]. PubMed: Protection by ornithine-aspartate of the effects of physical exercise. PubMed: [Radiophysical studies: irradiation of ornithine aspartate in the Siemens training reactor SUR 100]. PubMed: [Personal experiences in the treatment of internal diseases with ornithine aspartate]. PubMed: [Experiences with ornithine-aspartate in liver diseases]. PubMed: [On the therapy of liver diseases with ornithine aspartate]. PubMed: [Intravenous administration of ornithine aspartate to patients with hepatic diseases]. PubMed: Effect of ornithine-aspartate mixture on 15N-ammonia incorporation into urea in intact mice. PubMed: [Study of the treatment of liver damage due to several causes in tuberculosis, using ornithine-aspartate].